IMM-BCP-01

· Immunome, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMM-BCP-01, covering 2024-09-26 to 2024-09-26. Get the full timeline:

Most recent: Clinical Trial Update: IMM-BCP-01 in Mild to Moderate COVID-19 [Phase 1]